These data suggest that skeletal muscle SOCS3 is increased in conditions associated with obesity and insulin resistance, and may be an important molecule mediating obesity-, lipid-, and cytokine-induced insulin resistance. The gene discussed is SOCS3; the disease is obesity disorder.